Common Contracts

4 similar Underwriting Agreement contracts by Camp4 Therapeutics Corp, Immunome Inc., Kodiak Sciences Inc., Kyverna Therapeutics, Inc.

KODIAK SCIENCES INC. 6,956,522 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement
Underwriting Agreement • December 18th, 2025 • Kodiak Sciences Inc. • Biological products, (no disgnostic substances) • New York

Kodiak Sciences Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as Representatives (the “Representatives”), an aggregate of 6,956,522 shares of common stock, par value $0.0001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,043,478 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

Kyverna Therapeutics, Inc. 13,333,333 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • December 18th, 2025 • Kyverna Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

Kyverna Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 13,333,333 shares of common stock, par value $0.00001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,999,999 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

CAMP4 THERAPEUTICS CORPORATION 5,000,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreement • December 18th, 2025 • Camp4 Therapeutics Corp • Pharmaceutical preparations • New York

CAMP4 Therapeutics Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 5,000,000 shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Shares”). The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

Immunome, Inc. 18,625,000 Shares of Common Stock, par value $0.0001 per share Underwriting Agreement
Underwriting Agreement • December 17th, 2025 • Immunome Inc. • Pharmaceutical preparations • New York